thiazoles has been researched along with nvp-tae684 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boerman, OC; Fleuren, ED; Flucke, UE; Leenders, WP; Roeffen, MH; Schreuder, HW; van der Graaf, WT; Versleijen-Jonkers, YM; Vlenterie, M | 1 |
Appl, B; Eschenburg, G; Hundsdoerfer, P; Langemann, D; Najem, S; Reinshagen, K; Trochimiuk, M | 1 |
2 other study(ies) available for thiazoles and nvp-tae684
Article | Year |
---|---|
Expression and clinical relevance of MET and ALK in Ewing sarcomas.
Topics: Adolescent; Adult; Anaplastic Lymphoma Kinase; Anilides; Child; Child, Preschool; Chromosome Aberrations; Crizotinib; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Inhibitory Concentration 50; Male; Middle Aged; Neoplasm Metastasis; Proto-Oncogene Proteins c-met; Pyrazoles; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Recurrence; Sarcoma, Ewing; Tetrazolium Salts; Thiazoles; Treatment Outcome; Young Adult | 2013 |
Smac mimetic LCL161 supports neuroblastoma chemotherapy in a drug class-dependent manner and synergistically interacts with ALK inhibitor TAE684 in cells with ALK mutation F1174L.
Topics: Anaplastic Lymphoma Kinase; Cell Line, Tumor; Humans; Mutation; Neuroblastoma; Protein Kinase Inhibitors; Pyrimidines; Receptor Protein-Tyrosine Kinases; Thiazoles | 2016 |